Summary
Duchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
The global Duchenne Muscular Dystrophy market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Deflazacort
Prednisone
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
PTC Therapeutics
Sarepta Therapeutics
Bristol-Myers Squibb
ITALFARMACO
BioMarin
Daiichi Sankyo
Solid Biosciences
Summit Therapeutics
FibroGen
NS Pharma
Pfizer
ReveraGen BioPharma
Wave Life
Genethon
Santhera Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Male
Female
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Duchenne Muscular Dystrophy Picture
1.1.2 Specifications
Table Product Specifications of Duchenne Muscular Dystrophy
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market by Type, 2016-2026 (USD Million)
1.2.1.1 Deflazacort
Table Deflazacort Overview
1.2.1.2 Prednisone
Table Prednisone Overview
1.2.1.3 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market by Application, 2016-2026 (USD Million)
1.2.2.1 Male
Table Male Overview
1.2.2.2 Female
Table Female Overview
1.2.3 by Regions
Table Global Duchenne Muscular Dystrophy Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Duchenne Muscular Dystrophy
2.2 Upstream
Table Cost of Duchenne Muscular Dystrophy
Figure Manufacturing Process of Duchenne Muscular Dystrophy
2.3 Market
2.3.1 SWOT
Figure SWOT of Duchenne Muscular Dystrophy
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Duchenne Muscular Dystrophy
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Duchenne Muscular Dystrophy
3.4 Market Entry
Table Market Entry of Duchenne Muscular Dystrophy
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Deflazacort Market, 2016-2020
Figure Deflazacort Market Size and Growth, 2016-2020 (USD Million)
Figure Deflazacort Market Size and Growth, 2016-2020 (in Volume)
Table Deflazacort CAGR by Revenue and Volume, 2016-2020
4.1.2 Prednisone Market, 2016-2020
Figure Prednisone Market Size and Growth, 2016-2020 (USD Million)
Figure Prednisone Market Size and Growth, 2016-2020 (in Volume)
Table Prednisone CAGR by Revenue and Volume, 2016-2020
4.1.3 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Deflazacort Market Forecast, 2021-2026
Figure Deflazacort Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Deflazacort Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Deflazacort CAGR by Revenue and Volume, 2016-2026
4.2.2 Prednisone Market Forecast, 2021-2026
Figure Prednisone Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Prednisone Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Prednisone CAGR by Revenue and Volume, 2016-2026
4.2.3 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Male Market, 2016-2020
Figure Male Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Male CAGR by Revenue and Volume, 2016-2020
5.1.2 Female Market, 2016-2020
Figure Female Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Female CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Male Market Forecast, 2021-2026
Figure Male Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Male Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Male CAGR by Revenue and Volume, 2021-2026
5.2.2 Female Market Forecast, 2021-2026
Figure Female Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Female Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Female CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global Duchenne Muscular Dystrophy Market by Vendors, 2016-2020 (in Volume)
Table Global Duchenne Muscular Dystrophy Market Share by Vendors, 2016-2020 (USD Million)
Table Global Duchenne Muscular Dystrophy Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Duchenne Muscular Dystrophy Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 PTC Therapeutics
Table PTC Therapeutics Profile List
Table Microecological Modulator Operating Data of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Sarepta Therapeutics
Table Sarepta Therapeutics Profile List
Table Microecological Modulator Operating Data of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Bristol-Myers Squibb
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 ITALFARMACO
Table ITALFARMACO Profile List
Table Microecological Modulator Operating Data of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 BioMarin
Table BioMarin Profile List
Table Microecological Modulator Operating Data of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Daiichi Sankyo
Table Daiichi Sankyo Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Solid Biosciences
Table Solid Biosciences Profile List
Table Microecological Modulator Operating Data of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Summit Therapeutics
Table Summit Therapeutics Profile List
Table Microecological Modulator Operating Data of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 FibroGen
Table FibroGen Profile List
Table Microecological Modulator Operating Data of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 NS Pharma
Table NS Pharma Profile List
Table Microecological Modulator Operating Data of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 ReveraGen BioPharma
Table ReveraGen BioPharma Profile List
Table Microecological Modulator Operating Data of ReveraGen BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Wave Life
Table Wave Life Profile List
Table Microecological Modulator Operating Data of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Genethon
Table Genethon Profile List
Table Microecological Modulator Operating Data of Genethon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Santhera Pharmaceuticals
Table Santhera Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Santhera Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
List of Table
Table Product Specifications of Duchenne Muscular Dystrophy
Table Products Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market by Type, 2016-2026 (USD Million)
Table Deflazacort Overview
Table Prednisone Overview
Table Others Overview
Table Application Segment of Duchenne Muscular Dystrophy
Table Global Duchenne Muscular Dystrophy Market by Application, 2016-2026 (USD Million)
Table Male Overview
Table Female Overview
Table Global Duchenne Muscular Dystrophy Market by Region, 2016-2026 (USD Million)
Table Cost of Duchenne Muscular Dystrophy
Table Market Dynamics
Table Policy of Duchenne Muscular Dystrophy
Table GDP of Major Countries
Table Technology of Duchenne Muscular Dystrophy
Table Market Entry of Duchenne Muscular Dystrophy
Table Deflazacort CAGR by Revenue and Volume, 2016-2020
Table Prednisone CAGR by Revenue and Volume, 2016-2020
Table Others CAGR by Revenue and Volume, 2016-2020
Table Deflazacort CAGR by Revenue and Volume, 2016-2026
Table Prednisone CAGR by Revenue and Volume, 2016-2026
Table Others CAGR by Revenue and Volume, 2016-2026
Table Male CAGR by Revenue and Volume, 2016-2020
Table Female CAGR by Revenue and Volume, 2016-2020
Table Male CAGR by Revenue and Volume, 2021-2026
Table Female CAGR by Revenue and Volume, 2021-2026
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
Table North America CAGR by Revenue and Volume, 2016-2020
Table Europe CAGR by Revenue and Volume, 2016-2020
Table South America CAGR by Revenue and Volume, 2016-2020
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
Table North America CAGR by Revenue and Volume, 2021-2026
Table Europe CAGR by Revenue and Volume, 2021-2026
Table South America CAGR by Revenue and Volume, 2021-2026
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
Table Global Duchenne Muscular Dystrophy Market by Vendors, 2016-2020 (in Volume)
Table Global Duchenne Muscular Dystrophy Market Share by Vendors, 2016-2020 (USD Million)
Table Global Duchenne Muscular Dystrophy Market Share by Vendors, 2016-2020 (in Volume)
Table Price Factors List
Table PTC Therapeutics Profile List
Table Microecological Modulator Operating Data of PTC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sarepta Therapeutics Profile List
Table Microecological Modulator Operating Data of Sarepta Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ITALFARMACO Profile List
Table Microecological Modulator Operating Data of ITALFARMACO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BioMarin Profile List
Table Microecological Modulator Operating Data of BioMarin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Profile List
Table Microecological Modulator Operating Data of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Solid Biosciences Profile List
Table Microecological Modulator Operating Data of Solid Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Summit Therapeutics Profile List
Table Microecological Modulator Operating Data of Summit Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table FibroGen Profile List
Table Microecological Modulator Operating Data of FibroGen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table NS Pharma Profile List
Table Microecological Modulator Operating Data of NS Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ReveraGen BioPharma Profile List
Table Microecological Modulator Operating Data of ReveraGen BioPharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Wave Life Profile List
Table Microecological Modulator Operating Data of Wave Life (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genethon Profile List
Table Microecological Modulator Operating Data of Genethon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Santhera Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Santhera Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
List of Figure
Figure Duchenne Muscular Dystrophy Picture
Figure Industry Chain Structure of Duchenne Muscular Dystrophy
Figure Manufacturing Process of Duchenne Muscular Dystrophy
Figure SWOT of Duchenne Muscular Dystrophy
Figure Deflazacort Market Size and Growth, 2016-2020 (USD Million)
Figure Deflazacort Market Size and Growth, 2016-2020 (in Volume)
Figure Prednisone Market Size and Growth, 2016-2020 (USD Million)
Figure Prednisone Market Size and Growth, 2016-2020 (in Volume)
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Figure Deflazacort Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Deflazacort Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Prednisone Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Prednisone Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Male Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Female Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Male Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Male Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Female Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Female Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Duchenne Muscular Dystrophy Market Concentration by Region
Figure Marketing Channels Overview